Intense Pulsed Plus Low-Level Light Therapy in Meibomian Gland Dysfunction

References

• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification Report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
   PubMed Web of Science ®Google Scholar
• Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK. The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD. Invest Ophthalmol Vis Sci. 2011;52(4):1994–2005. doi:10.1167/iovs.10-6997e
   PubMed Web of Science ®Google Scholar
• Chhadva P, Goldhardt R, Galor A. Meibomian gland disease: the role of gland dysfunction in dry eye disease. Ophthalmology. 2017;124(11S):S20–6. doi:10.1016/j.ophtha.2017.05.031
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15(3):539–574.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Aragona P, Van Setten G, et al. Diagnosing the severity of dry eye: a clear and practical algorithm. Br J Ophthalmol. 2014;98(9):1168–1176. doi:10.1136/bjophthalmol-2013-304619
   PubMed Web of Science ®Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118(5):615–621. doi:10.1001/archopht.118.5.615
   PubMedGoogle Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15(3):575–628.
   PubMed Web of Science ®Google Scholar
• Craig JP, Chen Y-H, Turnbull PRK. Prospective trial of intense pulsed light for the treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2015;56(3):1965–1970. doi:10.1167/iovs.14-15764
   PubMed Web of Science ®Google Scholar
• Tashbayev B, Yazdani M, Arita R, Fineide F, Utheim TP. Intense pulsed light treatment in meibomian gland dysfunction: a concise review. Ocul Surf. 2020;18(4):583–594. doi:10.1016/j.jtos.2020.06.002
   PubMed Web of Science ®Google Scholar
• Rojas JC, Gonzalez-Lima F. Low-level light therapy of the eye and brain. Eye Brain. 2011;14(3):49–67.
   Google Scholar
• Toyos R. The effects of a red light technology on dry eye due to meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 2017;58(8):2236.
   Web of Science ®Google Scholar
• Stonecipher K, Abell TG, Chotiner B, Chotiner E, Potvin R. Combined low level light therapy and intense pulsed light therapy for the treatment of meibomian gland dysfunction. Clin Ophthalmol. 2019;13:993–999.
   PubMed Web of Science ®Google Scholar
• Vigo L, Giannaccare G, Sebastiani S, Pellegrini M, Carones F. Intense pulsed light for the treatment of dry eye owing to meibomian gland dysfunction. J Vis Exp. 2019; 146.
   Web of Science ®Google Scholar
• Albietz JM, Schmid KL. Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction. Clin Exp Optom. 2018;101(1):23–33. doi:10.1111/cxo.12541
   PubMed Web of Science ®Google Scholar
• Arita R, Mizoguchi T, Fukuoka S, Morishige N. Multicenter study of intense pulsed light therapy for patients with refractory meibomian gland dysfunction. Cornea. 2018;37(12):1566–1571. doi:10.1097/ICO.0000000000001687
   PubMed Web of Science ®Google Scholar
• Yin Y, Liu N, Gong L, Song N. Changes in the meibomian gland after exposure to intense pulsed light in Meibomian Gland Dysfunction (MGD) Patients. Curr Eye Res. 2018;43(3):308–313. doi:10.1080/02713683.2017.1406525
   PubMed Web of Science ®Google Scholar
• Arita R, Fukuoka S, Morishige N. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Ocul Surf. 2019;17(1):104–110. doi:10.1016/j.jtos.2018.11.004
   PubMed Web of Science ®Google Scholar
• Cheng S-N, Jiang F-G, Chen H, Gao H, Huang Y-K. Intense pulsed light therapy for patients with meibomian gland dysfunction and ocular demodex infestation. Curr Med Sci. 2019;39(5):800–809. doi:10.1007/s11596-019-2108-1
   PubMed Web of Science ®Google Scholar
• Piyacomn Y, Kasetsuwan N, Reinprayoon U, Satitpitakul V, Tesapirat L. Efficacy and safety of intense pulsed light in patients with meibomian gland dysfunction-a randomized, double-masked, sham-controlled Clinical Trial. Cornea. 2020;39(3):325–332. doi:10.1097/ICO.0000000000002204
   PubMed Web of Science ®Google Scholar
• Karaca EE, Evren Kemer Ö, Özek D. Intense regulated pulse light for the meibomian gland dysfunction. Eur J Ophthalmol. 2020;30(2):289–292. doi:10.1177/1120672118817687
   PubMed Web of Science ®Google Scholar
• Arita R, Fukuoka S, Mizoguchi T, Morishige N. Multicenter study of intense pulsed light for patients with refractory aqueous-deficient dry eye accompanied by mild meibomian gland dysfunction. J Clin Med. 2020;9(11):3467. doi:10.3390/jcm9113467
   Web of Science ®Google Scholar
• Goo H, Kim H, Ahn J, Cho K. Effects of low-level light therapy at 740 nm on dry eye disease in vivo. Med Lasers. 2019;8(2):50–58. doi:10.25289/ML.2019.8.2.50
   Google Scholar
• Vigo L, Taroni L, Bernabei F, et al. Ocular surface workup in patients with meibomian gland dysfunction treated with intense regulated pulsed light. Diagnostics (Basel). 2019;9(4). doi:10.3390/diagnostics9040147
   Google Scholar
• Dell SJ, Gaster RN, Barbarino SC, Cunningham DN. Prospective evaluation of intense pulsed light and meibomian gland expression efficacy on relieving signs and symptoms of dry eye disease due to meibomian gland dysfunction. Clin Ophthalmol. 2017;11:817–827. doi:10.2147/OPTH.S130706
   PubMed Web of Science ®Google Scholar
• Gomes JAP, Azar DT, Baudouin C, et al. TFOS DEWS II iatrogenic report. Ocul Surf. 2017;15(3):511–538.
   PubMed Web of Science ®Google Scholar
• Craig JP, Nelson JD, Azar DT, et al. TFOS DEWS II Report executive summary. Ocul Surf. 2017;15(4):802–812. doi:10.1016/j.jtos.2017.08.003
   PubMed Web of Science ®Google Scholar
• Suzuki M, Massingale ML, Ye F, et al. Tear osmolarity as a biomarker for dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51(9):4557–4561. doi:10.1167/iovs.09-4596
   PubMed Web of Science ®Google Scholar
• Jiang X, Lv H, Song H, et al. Evaluation of the safety and effectiveness of intense pulsed light in the treatment of meibomian gland dysfunction. J Ophthalmol. 2016;2016:1910694. doi:10.1155/2016/1910694
   PubMed Web of Science ®Google Scholar
• Rong B, Tang Y, Tu P, et al. Intense pulsed light applied directly on eyelids combined with meibomian gland expression to treat meibomian gland dysfunction. Photomed Laser Surg. 2018;36(6):326–332. doi:10.1089/pho.2017.4402
   PubMed Web of Science ®Google Scholar
• Seo KY, Kang SM, Ha DY, Chin HS, Jung JW. Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction. Cont Lens Anterior Eye. 2018;41(5):430–435. doi:10.1016/j.clae.2018.06.002
   PubMed Web of Science ®Google Scholar
• Rong B, Tang Y, Liu R, et al. Long-term effects of intense pulsed light combined with meibomian gland expression in the treatment of meibomian gland dysfunction. Photomed Laser Surg. 2018;36(10):562–567. doi:10.1089/pho.2018.4499
   PubMed Web of Science ®Google Scholar
• Choi M, Han SJ, Ji YW, et al. Meibum expressibility improvement as a therapeutic target of intense pulsed light treatment in meibomian gland dysfunction and its association with tear inflammatory cytokines. Sci Rep. 2019;9(1):7648. doi:10.1038/s41598-019-44000-0
   PubMed Web of Science ®Google Scholar
• Gao Y-F, Liu R-J, Li Y-X, et al. Comparison of anti-inflammatory effects of intense pulsed light with tobramycin/dexamethasone plus warm compress on dry eye associated meibomian gland dysfunction. Int J Ophthalmol. 2019;12(11):1708–1713. doi:10.18240/ijo.2019.11.07
   Web of Science ®Google Scholar